@article{cb6fad8a4f0644a9985b9bbb2b910442,
title = "DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial",
keywords = "Epigenetic signature, DNA methylation, Predictive biomarker, Chemotherapy, Oesophageal adenocarcinoma, GASTRIC-CANCER, OPEN-LABEL, PERIOPERATIVE CHEMOTHERAPY, METHYLATION, CAPECITABINE, RESECTION, SURGERY",
author = "Raghav Sundar and Alvin Ng and Hermioni Zouridis and Nisha Padmanabhan and Taotao Sheng and Shenli Zhang and Lee, {Ming Hui} and Ooi, {Wen Fong} and Aditi Qamra and Imran Inam and Hewitt, {Lindsay C.} and So, {Jimmy Bok-Yan} and Vivien Koh and Nankivell, {Matthew G.} and Langley, {Ruth E.} and Allum, {William H.} and David Cunningham and Rozen, {Steven G.} and Yong, {Wei Peng} and Grabsch, {Heike I.} and Patrick Tan",
year = "2019",
month = dec,
doi = "10.1016/j.ejca.2019.09.016",
language = "English",
volume = "123",
pages = "48--57",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER SCI LTD",
}